FDA Approved: LOTEPREDNOL ETABONATE AND TOBRAMYCIN — Supplemental Application (Bausch & Lomb Americas Inc.)

View source ↗

Summary

The FDA approved a supplemental application for the ophthalmic combination Loteprednol etabonate and tobramycin (brand Zylet) from Bausch & Lomb Americas Inc., …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis
• Inflammation of the Eye

Drugs mentioned

• Zylet (loteprednol etabonate and tobramycin)

Snippet

SUPPL AP for LOTEPREDNOL ETABONATE AND TOBRAMYCIN (LOTEPREDNOL ETABONATE AND TOBRAMYCIN)